Insights
Publications

CBD in Foods and Beverages? Not Quite Yet

March 18, 2019 Articles

Originally published by Food Processing.

The 2018 Farm Bill may have laid the groundwork for getting CBD products on the shelves.

On Oct. 27, 2018, the New York Times ran an article with the headline Why is CBD Everywhere?, noting that products infused with cannabidiol, a compound found in cannabis plants commonly referred to as “CBD,” had gone from being obscure to omnipresent almost overnight.

Seemingly within the blink of an eye, consumers could purchase CBD infused donuts, lattes, dog treats, cookies and the list goes on. Forbes even reported that Coca-Cola was considering developing a CBD infused beverage. While CBD is non-psychoactive – meaning it won’t get you high – it has been touted as having certain therapeutic benefits for dealing with pain, inflammation and general anxiety.

Despite the commercial availability of food products containing CBD, whether such products can be manufactured legally has been (and continues to be) uncertain. Although many manufacturers will sell food and dietary supplements containing CBD across the country (the marijuana delivery service Eaze through its “Eaze Wellness” platform, for instance, will ship CBD products to 41 states and the District of Columbia), major retailers generally do not sell products containing CBD, nor are they available on major consumer platforms such as Amazon.

In addition, sellers using payment platforms such as Shopify can only process payments using “high risk” gateways, and have generally been unsuccessful using large, commercial banks to process wire transfers for raw materials. Adding to the uncertainty, authorities in recent weeks have started cracking down on CBD products, with enforcement actions taken in Michigan, Florida, Maine, Nebraska, Ohio, New York and possibly elsewhere.

For some background, CBD can be extracted from both “marijuana” and “hemp.” Hemp is defined in the Agriculture Improvements Act of 2018, also known as the 2018 Farm Bill, as the Cannabis sativa L. plant with a THC concentration of not more than 0.3 percent on a dry weight basis. While the 2018 Farm Bill paved the way for large-scale agricultural production of hemp, until state and federal regulations are finalized to implement the new law, hemp may only be grown under a 2014 pilot program for agricultural or academic research.

The 2018 Farm Bill, importantly, removed hemp – including any of its “derivatives, extracts [and] cannabinoids” – from the definition of “marijuana” under the Controlled Substances Act of 1970. As a result, at first glance it appeared as though CBD extracted from hemp would be legal under federal law. Importantly, however, the 2018 Farm Bill explicitly states that the new law does not affect or modify the authority of the FDA from issuing regulations and guidelines that relate to the use of hemp in foods.

Frustrating some lawmakers, on the day that the 2018 Farm Bill was signed into law, FDA Commissioner Scott Gottlieb issued a sweeping statement that, although certain hemp products – such as hemp seeds, hemp seed protein and hemp seed oil – are generally recognized as safe food additives, it is unlawful “to introduce food containing added CBD…into interstate commerce, or to market CBD…products as, or in, dietary supplements, regardless of whether the substances are hemp-derived.”

While Gottlieb’s statement mentions that there are “pathways available for those who seek to lawfully introduce these products into interstate commerce” and that the “FDA will continue to take steps to make the pathways for the lawful marketing of these products more efficient,” aside from undergoing clinical studies it remained unclear what these “pathways” are.

Although Commissioner Gottlieb said in late February that the FDA will hold hearings in April on how best to regulate CBD derived from hemp, Gottlieb abruptly announced his resignation only a few days later putting the regulatory process in limbo (and sending cannabis stocks tumbling as a result).

In light of the uncertainty at the federal level, states have begun attempting to take matters into their own hands. For instance, in California Assembly Bill 228 was introduced in January to clarify that existing state law may not prohibit restrictions on the sale of food, beverages or cosmetics that include hemp-derived CBD. While the state law would not interfere with the FDA’s jurisdiction to regulate products in interstate commerce, it would prevent the state’s department of Public Health from taking enforcement actions against manufacturers of products containing CBD.

Firm Highlights

Publication

Evicting Tenants Over “Illegal” Cannabis Operation Comes Back to Bite Landlords in Coverage

A 6th Circuit case decided earlier this year demonstrates how positions taken by insureds in prior litigation can impact or foreclose coverage in subsequent disputes with insurers. See K.V.G. Properties, Inc. v. Westfield Ins....

Read More
Publication

Will It Go Forward? First Cannabis Patent Infringement Case Filed in Federal Court

A patent infringement case pending in front of the U.S. District Court for the District of Colorado has the potential to set an important precedent that will have ramifications for many of our clients...

Read More
Publication

Doing Business With the Cannabis Industry? Make Sure Your Insurance Will Cover You

By Shanti Eagle, Farella Braun + Martel, and Martin Fox-Foster, Emergent Risk Insurance Services Much has been written about the difficulties and limitations of insuring leaf-touching cannabis businesses. However, any individual or company simply interacting...

Read More
Event

Insurance for the Cannabis Industry

Shanti Eagle is the moderator of this BASF Insurance Section program co-sponsored with the Cannabis Section. This panel will provide important risk management and insurance placement advice to those dealing with businesses involved in cannabis...

Read More
Publication

Insuring Cannabis: Not Business As Usual, Yet

The legalization of cannabis in many states is helping the industry to become mainstream and gain access to insurance products taken for granted in other economic sectors.   But there is still a long...

Read More
Event

North Coast Cannabis Industry Conference

Farella Braun + Martel is proud to underwrite the North Coast Cannabis Industry Conference featuring keynote speaker Aaron Smith, co-founder and executive director of the National Cannabis Industry Association. The event will also feature...

Read More
News

Farella Braun + Martel Advises Cannabis Distributor Blackbird Holdings Corp. in Sale to TILT Holdings Inc. for $50 Million

SAN FRANCISCO (January 29, 2019): Farella Braun + Martel represented Blackbird Holdings Corp. , a distribution company providing operations and software solutions that facilitate the movement of cannabis products at each touchpoint within the...

Read More
News

Prior Litigation Can Impact Coverage in Future Disputes

GlobeSt.com March 6, 2019 "Prior Litigation Can Impact Coverage in Future Disputes" Insurance Recovery Senior Associate Shanti Eagle discusses how positions taken by insureds in prior litigation can impact or foreclose coverage in subsequent disputes...

Read More